MOLN - Financial Reports List - Molecular Partners AG - IntrinsicAlpha

Molecular Partners AG MOLN

Healthcare - Biotechnology - NASDAQ - CH

$ 3.54

-3.8 %

$ 131 M

Market Cap

-1.96

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	43.22%	11.14%
Annual Report	FY	10-K	2024-12-31	-29.38%	12.81%	-0.18%
Quarterly Report	Q3	8-K	2024-09-30	-73.20%	-43.40%	-8.15%
Quarterly Report	Q2	8-K	2024-06-30	273.73%	5.66%	-0.59%
Quarterly Report	Q1	8-K	2024-03-31	-10.23%	26.09%	-5.10%
Quarterly Report	Q4	8-K	2023-12-31	-61.68%	0.63%	-11.32%
Annual Report	FY	10-K	2023-12-31	-96.29%	-52.59%	-52.40%
Quarterly Report	Q3	8-K	2023-09-30	8.73%	4.29%	8.19%
Quarterly Report	Q2	8-K	2023-06-30	-96.47%	-499.66%	-152.35%
Quarterly Report	Q1	8-K	2023-03-31	-98.23%	-10.01%	-9.89%

1